B. Malmgren
YOU?
Author Swipe
Abnormalities in Tooth Formation after Early Bisphosphonate Treatment in Children with Osteogenesis Imperfecta Open
Treatment with intravenous bisphosphonate (BP) in children and adolescents with osteogenesis imperfecta (OI) started in Sweden in 1991. No human studies on the role of BP therapy in development of disturbances in tooth mineralization or to…
View article: Bisphosphonate Therapy and Tooth Development in Children and Adolescents with Osteogenesis Imperfecta
Bisphosphonate Therapy and Tooth Development in Children and Adolescents with Osteogenesis Imperfecta Open
Osteogenesis imperfecta (OI) is a heterogeneous connective tissue disorder characterized by repeated fractures and skeletal disorders. At present, bisphosphonate (BP) therapy is the gold standard for OI treatment. The present retrospective…
Dentinogenesis imperfecta type II in Swedish children and adolescents Open
These results show a significantly lower prevalence of DGI type II than previously reported and point to the importance of excluding OI in children with DGI.
View article: Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta – A retrospective cohort study
Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta – A retrospective cohort study Open
Osteogenesis imperfecta (OI) is a heterogeneous group of disorders of connective tissue, caused mainly by mutations in the collagen I genes (COL1A1 and COL1A2). Dentinogenesis imperfecta (DGI) and other dental aberrations are common featur…